Research/Clinical Trial Update April 2020: Atezolizumab and the IMpassion130 Trial

Synopsised by Dr. Ann Hopkins Atezolizumab is quite a new drug which belongs to a growing family of medicines called “cancer immunotherapies” – drugs that help a patient’s own immune system kick in and kill tumour cells. Any drug name that ends in “mab” stands for monoclonal antibody. Monoclonal antibodies are not chemical drugs synthesised …